521 related articles for article (PubMed ID: 25027965)
1. Evaluation of non-invasive prenatal testing (NIPT) for aneuploidy in an NHS setting: a reliable accurate prenatal non-invasive diagnosis (RAPID) protocol.
Hill M; Wright D; Daley R; Lewis C; McKay F; Mason S; Lench N; Howarth A; Boustred C; Lo K; Plagnol V; Spencer K; Fisher J; Kroese M; Morris S; Chitty LS
BMC Pregnancy Childbirth; 2014 Jul; 14():229. PubMed ID: 25027965
[TBL] [Abstract][Full Text] [Related]
2. Non-invasive prenatal testing for fetal chromosomal abnormalities by low-coverage whole-genome sequencing of maternal plasma DNA: review of 1982 consecutive cases in a single center.
Lau TK; Cheung SW; Lo PS; Pursley AN; Chan MK; Jiang F; Zhang H; Wang W; Jong LF; Yuen OK; Chan HY; Chan WS; Choy KW
Ultrasound Obstet Gynecol; 2014 Mar; 43(3):254-64. PubMed ID: 24339153
[TBL] [Abstract][Full Text] [Related]
3. Uptake, outcomes, and costs of implementing non-invasive prenatal testing for Down's syndrome into NHS maternity care: prospective cohort study in eight diverse maternity units.
Chitty LS; Wright D; Hill M; Verhoef TI; Daley R; Lewis C; Mason S; McKay F; Jenkins L; Howarth A; Cameron L; McEwan A; Fisher J; Kroese M; Morris S
BMJ; 2016 Jul; 354():i3426. PubMed ID: 27378786
[TBL] [Abstract][Full Text] [Related]
4. Use of cell-free fetal DNA in maternal plasma for noninvasive prenatal screening.
Wagner AJ; Mitchell ME; Tomita-Mitchell A
Clin Perinatol; 2014 Dec; 41(4):957-66. PubMed ID: 25459783
[TBL] [Abstract][Full Text] [Related]
5. Implementation of non-invasive prenatal testing by semiconductor sequencing in a genetic laboratory.
Dheedene A; Sante T; De Smet M; Vanbellinghen JF; Grisart B; Vergult S; Janssens S; Menten B
Prenat Diagn; 2016 Aug; 36(8):699-707. PubMed ID: 27176606
[TBL] [Abstract][Full Text] [Related]
6. [Combined first trimester screening and cell-free fetal DNA - “next generation screening”].
Kagan KO; Eiben B; Kozlowski P
Ultraschall Med; 2014 Jun; 35(3):229-36. PubMed ID: 24764214
[TBL] [Abstract][Full Text] [Related]
7. Non-invasive prenatal testing for trisomies 21, 18 and 13: clinical experience from 146,958 pregnancies.
Zhang H; Gao Y; Jiang F; Fu M; Yuan Y; Guo Y; Zhu Z; Lin M; Liu Q; Tian Z; Zhang H; Chen F; Lau TK; Zhao L; Yi X; Yin Y; Wang W
Ultrasound Obstet Gynecol; 2015 May; 45(5):530-8. PubMed ID: 25598039
[TBL] [Abstract][Full Text] [Related]
8. Implementation of cell-free DNA-based non-invasive prenatal testing in a National Health Service Regional Genetics Laboratory.
Togneri FS; Kilby MD; Young E; Court S; Williams D; Griffiths MJ; Allen SK
Genet Res (Camb); 2019 Dec; 101():e11. PubMed ID: 31813398
[TBL] [Abstract][Full Text] [Related]
9. Prenatal screening for fetal aneuploidy in singleton pregnancies.
Chitayat D; Langlois S; Douglas Wilson R; ;
J Obstet Gynaecol Can; 2011 Jul; 33(7):736-750. PubMed ID: 21749752
[TBL] [Abstract][Full Text] [Related]
10. Noninvasive prenatal testing in routine clinical practice--an audit of NIPT and combined first-trimester screening in an unselected Australian population.
McLennan A; Palma-Dias R; da Silva Costa F; Meagher S; Nisbet DL; Scott F
Aust N Z J Obstet Gynaecol; 2016 Feb; 56(1):22-8. PubMed ID: 26817523
[TBL] [Abstract][Full Text] [Related]
11. Clinical implementation of routine screening for fetal trisomies in the UK NHS: cell-free DNA test contingent on results from first-trimester combined test.
Gil MM; Revello R; Poon LC; Akolekar R; Nicolaides KH
Ultrasound Obstet Gynecol; 2016 Jan; 47(1):45-52. PubMed ID: 26498918
[TBL] [Abstract][Full Text] [Related]
12. Analysis of cell-free fetal DNA in maternal blood for detection of trisomy 21, 18 and 13 in a general pregnant population and in a high risk population - a systematic review and meta-analysis.
Iwarsson E; Jacobsson B; Dagerhamn J; Davidson T; Bernabé E; Heibert Arnlind M
Acta Obstet Gynecol Scand; 2017 Jan; 96(1):7-18. PubMed ID: 27779757
[TBL] [Abstract][Full Text] [Related]
13. A new era in prenatal care: non-invasive prenatal testing in Switzerland.
Manegold-Brauer G; Kang Bellin A; Hahn S; De Geyter C; Buechel J; Hoesli I; Lapaire O
Swiss Med Wkly; 2014 Feb; 144():w13915. PubMed ID: 24549748
[TBL] [Abstract][Full Text] [Related]
14. Trial by Dutch laboratories for evaluation of non-invasive prenatal testing. Part II-women's perspectives.
van Schendel RV; Page-Christiaens GC; Beulen L; Bilardo CM; de Boer MA; Coumans AB; Faas BH; van Langen IM; Lichtenbelt KD; van Maarle MC; Macville MV; Oepkes D; Pajkrt E; Henneman L;
Prenat Diagn; 2016 Dec; 36(12):1091-1098. PubMed ID: 27739584
[TBL] [Abstract][Full Text] [Related]
15. Trial by Dutch laboratories for evaluation of non-invasive prenatal testing. Part I-clinical impact.
Oepkes D; Page-Christiaens GC; Bax CJ; Bekker MN; Bilardo CM; Boon EM; Schuring-Blom GH; Coumans AB; Faas BH; Galjaard RH; Go AT; Henneman L; Macville MV; Pajkrt E; Suijkerbuijk RF; Huijsdens-van Amsterdam K; Van Opstal D; Verweij EJ; Weiss MM; Sistermans EA;
Prenat Diagn; 2016 Dec; 36(12):1083-1090. PubMed ID: 27750376
[TBL] [Abstract][Full Text] [Related]
16. DNA sequencing versus standard prenatal aneuploidy screening.
Bianchi DW; Parker RL; Wentworth J; Madankumar R; Saffer C; Das AF; Craig JA; Chudova DI; Devers PL; Jones KW; Oliver K; Rava RP; Sehnert AJ;
N Engl J Med; 2014 Feb; 370(9):799-808. PubMed ID: 24571752
[TBL] [Abstract][Full Text] [Related]
17. Women's Experiences and Preferences for Service Delivery of Non-Invasive Prenatal Testing for Aneuploidy in a Public Health Setting: A Mixed Methods Study.
Lewis C; Hill M; Chitty LS
PLoS One; 2016; 11(4):e0153147. PubMed ID: 27045195
[TBL] [Abstract][Full Text] [Related]
18. [Retrospective analysis of cell-free fetal DNA prenatal testing of maternal peripheral blood].
Wei Y; Wang R; Xi M; Wei L; Zhu W; Liu Y
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2023 Aug; 40(8):933-938. PubMed ID: 37532491
[TBL] [Abstract][Full Text] [Related]
19. Use of a DNA method, QF-PCR, in the prenatal diagnosis of fetal aneuploidies.
Langlois S; Duncan A; ;
J Obstet Gynaecol Can; 2011 Sep; 33(9):955-960. PubMed ID: 21923994
[TBL] [Abstract][Full Text] [Related]
20. Noninvasive Prenatal Testing for Trisomies 21, 18, and 13, Sex Chromosome Aneuploidies, and Microdeletions: A Health Technology Assessment.
Health Quality Ontario
Ont Health Technol Assess Ser; 2019; 19(4):1-166. PubMed ID: 30847010
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
